Yahoo! Finance Search - Finance Home - Yahoo! - Help

Sunday, September 25 2016 11:09pm ET - U.S. Markets Closed.
Industry Center - Drug Manufacturers - Other
Industry Center > Drug Manufacturers - Other > News
More On This Industry
· Summary
News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
 
Drug Manufacturers - Other News
Latest News
Friday, Sep 23, 2016
·The Hot Stock: Endo International Soars 15% on CEO Swap
at Barrons.com - Fri 4:51 pm ET
·Endo Shuffles the Deck With New CEO Appointment
- Fri Sep 23
·Change at the top: Endo names new CEO
at bizjournals.com - Fri Sep 23
·Teva: This Is No Generic Downtrend
at TheStreet.com - Fri Sep 23
·Endo (ENDP) Stock Soars After Campanelli Named CEO
at TheStreet.com - Fri Sep 23
·Synergy Pharmaceuticals to Present at OctoberINVESTfest 2016
Business Wire - Fri Sep 23
·Endo Replaces CEO De Silva With Campanelli After Stock Slump
at Bloomberg - Fri Sep 23
·Apricus Biosciences Announces $4.6 Million Registered Direct Offering
Thomson Reuters ONE - Fri Sep 23
·Apricus Biosciences Announces $4.6 Million Registered Direct Offering
GlobeNewswire - Fri Sep 23
·Endo CEO De Silva steps down, replaced by former Par CEO
at MarketWatch - Fri Sep 23
·Endo Names Paul Campanelli President and Chief Executive Officer
CNW Group - Fri Sep 23
·Endo Names Paul Campanelli President and Chief Executive Officer
PR Newswire - Fri Sep 23
·Amphastar Pharmaceuticals Inc (AMPH) CEO & Chief Science Officer Jack Y. Zhang Sold $9. ...
- Thu Sep 22
Thursday, Sep 22, 2016
·Teva Announces Positive Top-Line Data from Second Phase III Study of SD-809 in Tardive Dyskinesia (TD)
Business Wire - Thu Sep 22
Wednesday, Sep 21, 2016
·Apricus Biosciences Announces the Launch of VitarosĀ® in the Czech Republic and Slovakia by Recordati
Thomson Reuters ONE - Wed Sep 21
·Apricus Biosciences Announces the Launch of VitarosĀ® in the Czech Republic and Slovakia by Recordati
GlobeNewswire - Wed Sep 21
·Regeneron to Collaborate With Teva for Fasinumab Drug (REGN, TEVA)
at Investopedia - Wed Sep 21
Tuesday, Sep 20, 2016
·Report: Depomed Is Attempting to Sell Itself
at Investopedia - Tue Sep 20
·Apricus Biosciences Announces Completion of Transfer of the Marketing Authorizations for VitarosĀ® in Finland and Denmark to Ferring Pharmaceuticals
Thomson Reuters ONE - Tue Sep 20
·Regeneron and Teva Announce Global Collaboration to Develop and Commercialize Fasinumab, an Investigational NGF Antibody for Chronic Pain
PR Newswire - Tue Sep 20
More Latest News...
  

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drug Manufacturers - Other Headlines
More Finance RSS Feeds


Copyright © 2016 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2016 Morningstar, Inc. All Rights Reserved. Company information © 2016 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2016, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?